Status:
COMPLETED
Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.
Eligibility Criteria
Inclusion
- Diagnosis of ankylosing spondylitis
Exclusion
- Contraindications according SmPC
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2007
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00227227
Start Date
May 1 2004
End Date
June 1 2007
Last Update
December 10 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Berlin, Germany, 10719